mRNA |
crizotinib:PLX-4032 (2:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
-0.017 |
0.6 |
mRNA |
5-FU |
CTRPv2 |
pan-cancer |
AAC |
0.017 |
0.6 |
mRNA |
MG-132 |
CTRPv2 |
pan-cancer |
AAC |
-0.03 |
0.6 |
mRNA |
avicin D |
CTRPv2 |
pan-cancer |
AAC |
0.026 |
0.6 |
mRNA |
BRD-K04800985 |
CTRPv2 |
pan-cancer |
AAC |
0.018 |
0.6 |
mRNA |
MLN2480 |
CTRPv2 |
pan-cancer |
AAC |
0.026 |
0.6 |
mRNA |
L-685458 |
CCLE |
pan-cancer |
AAC |
-0.022 |
0.6 |
mRNA |
SID 26681509 |
CTRPv2 |
pan-cancer |
AAC |
0.018 |
0.6 |
mRNA |
sirolimus:bortezomib (250:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.015 |
0.7 |
mRNA |
BRD-K27986637 |
CTRPv2 |
pan-cancer |
AAC |
-0.033 |
0.7 |